News
SDMHF
239.00
NaN%
--
Jefferies Sticks to Their Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 1d ago
Sartorius Stedim Biotech (0RG8) Receives a Buy from Goldman Sachs
TipRanks · 4d ago
RBC Capital Reaffirms Their Buy Rating on Sartorius Stedim Biotech (0RG8)
TipRanks · 4d ago
Sartorius Stedim Biotech (0RG8) Gets a Buy from Jefferies
TipRanks · 5d ago
Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.84, revenue of €2.29B
Seeking Alpha · 5d ago
J.P. Morgan Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 5d ago
Sartorius Stedim Biotech Delivers Strong 2026 Growth and Confirms Outlook
TipRanks · 5d ago
Sartorius Stedim Biotech (0RG8) Receives a Buy from UBS
TipRanks · 10/15 12:36
RBC Capital Remains a Buy on Sartorius Stedim Biotech (0RG8)
TipRanks · 10/06 07:55
Sartorius Stedim Biotech Updates Share Capital and Voting Rights
TipRanks · 10/01 14:38
Goldman Sachs Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 10/01 12:55
Sartorius Stedim Biotech (0RG8) Receives a Buy from Barclays
TipRanks · 09/30 20:05
J.P. Morgan Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
TipRanks · 09/28 06:35
Baron International Growth Fund adds new positions in SDMHF, SPOT; exits seven positions.
Seeking Alpha · 09/17 17:59
Baron Health Care Fund adds SDMHF; exits SYK
Seeking Alpha · 09/17 14:19
Baron Health Care Fund Q2 2026 Portfolio Activity
Seeking Alpha · 09/16 12:54
Baron International Growth Fund Q2 2026 Portfolio Activity
Seeking Alpha · 09/15 19:09
Sartorius Stedim Biotech (0RG8) Gets a Buy from Barclays
TipRanks · 09/08 07:25
Sartorius Stedim Biotech Updates Share Capital and Voting Rights Structure
TipRanks · 09/03 14:35
Sartorius Stedim upgraded to Buy from Neutral at UBS
TipRanks · 08/20 08:45
More
Webull provides a variety of real-time SDMHF stock news. You can receive the latest news about Sartorius Stedim through multiple platforms. This information may help you make smarter investment decisions.
About SDMHF
Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.